Market Opportunity


U.S. Market | Lung Disease

Pure Scientific Technologies plans to engage key research hospital sites in the U.S. for further development and testing of its products. The current COVID-19 pandemic has put treatment of pulmonary conditions in the forefront of medical priorities.

Our approach of high drug delivery to the target site rather than systemic delivery holds great opportunity as the respiratory system has a large surface area with high bio-availability and the capacity to absorb large quantities of drug making it an optimal delivery.

CDC reports 2018 Asthma incidents

Reported cases having at least 1 asthma attack annually

American Cancer Society 2019 lung cancer incidents

CDC reports 2019 COPD (emphysema, chronic bronchitis)

U.S. Market | CBD

CBD industry projected market size in the U.S. by 2025


Percentage of Americans use CBD for anxiety, depression, arthritis, insomnia, as well as other indications

U.S. Market | CBD


The addition of Heliox to normal daily CBD usage will not significantly impact costs associated with normal regular usage. CBD is non-toxic even in relatively large doses and is typically not associated with any serious or long-term side effects

While CBD can be delivered in numerous ways, inhalation is considered the most effective method and is preferred by many users as the lungs offer a large surface for rapid absorption with immediate effect